https://regulatorynews.com/sava-ascensia-series-b-glucose-microsensor Regulatory News en 2026-10-11T09:31:52-04:00 Sava Lands $36M Series B Led by Ascensia https://regulatorynews.com/trexbio-nasdaq-ipo-treg-financing Regulatory News en 2026-10-11T09:31:52-04:00 TRexBio Raises $117M in Nasdaq IPO for Treg Drug https://regulatorynews.com/wellysis-s-patch-cardioai-fda-clearance Regulatory News en 2026-10-11T09:31:52-04:00 Wellysis Wins FDA Clearance for S-Patch CardioAI https://regulatorynews.com/philips-lumify-ultrasound-early-alert Regulatory News en 2026-10-11T05:59:09-04:00 FDA Links Philips Lumify Ultrasound Bug to Four Deaths https://regulatorynews.com/pritelivir-hovilpri-hsv-approval Regulatory News en 2026-10-11T05:59:09-04:00 FDA Approves Hovilpri for Drug-Resistant Herpes Lesions https://regulatorynews.com/ultragenyx-priority-review-voucher-sale Regulatory News en 2026-10-11T05:59:09-04:00 Ultragenyx Sells Priority Review Voucher for $210M https://regulatorynews.com/brevital-methohexital-recall-anesthesia-ect Regulatory News en 2026-10-10T10:58:26-04:00 Brevital Recall Hits an OR and ECT Anesthesia Drug https://regulatorynews.com/ny-measles-emergency-mmr-vaccination-authority Regulatory News en 2026-10-10T10:58:26-04:00 NY Declares Measles Emergency, Widens Who Can Vaccinate https://regulatorynews.com/argus-cognitive-neurora-fda-clearance Regulatory News en 2026-10-10T09:40:14-04:00 Argus Cognitive Earns FDA Clearance for Neurora https://regulatorynews.com/medical-microinstruments-symani-series-d-financing Regulatory News en 2026-10-10T09:40:14-04:00 Medical Microinstruments Lands $125M for Symani https://regulatorynews.com/vir-biotechnology-vir-5500-fast-track-designation Regulatory News en 2026-10-10T09:40:14-04:00 Vir Biotechnology Wins FDA Fast Track for VIR-5500 https://regulatorynews.com/ema-pre-cta-pilot-permanent Regulatory News en 2026-10-10T06:03:25-04:00 EMA Makes Pre-CTA Trial Advice Pilot Permanent https://regulatorynews.com/fda-biosimilar-manufacturing-changes-guidance-final Regulatory News en 2026-10-10T06:03:25-04:00 FDA Finalizes Biosimilar Manufacturing-Change Rules https://regulatorynews.com/par-health-brevital-sodium-recall Regulatory News en 2026-10-10T06:03:25-04:00 Par Health Recalls Brevital Sodium Over Cellulose https://regulatorynews.com/tecentriq-adjuvant-dmmr-colon-cancer-approval Regulatory News en 2026-10-09T10:57:15-04:00 FDA Approves First Adjuvant Immunotherapy for Colon Cancer